238 related articles for article (PubMed ID: 27335156)
21. Clozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital.
Brown D; Larkin F; Sengupta S; Romero-Ureclay JL; Ross CC; Gupta N; Vinestock M; Das M
CNS Spectr; 2014 Oct; 19(5):391-402. PubMed ID: 24698103
[TBL] [Abstract][Full Text] [Related]
22. The pharmacological management of violence in schizophrenia: a structured review.
Topiwala A; Fazel S
Expert Rev Neurother; 2011 Jan; 11(1):53-63. PubMed ID: 21158555
[TBL] [Abstract][Full Text] [Related]
23. The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review.
Shah P; Iwata Y; Plitman E; Brown EE; Caravaggio F; Kim J; Nakajima S; Hahn M; Remington G; Gerretsen P; Graff-Guerrero A
Psychiatry Res; 2018 Oct; 268():114-122. PubMed ID: 30015109
[TBL] [Abstract][Full Text] [Related]
24. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia.
Liu SK; Fitzgerald PB; Daigle M; Chen R; Daskalakis ZJ
Biol Psychiatry; 2009 Mar; 65(6):503-9. PubMed ID: 18950746
[TBL] [Abstract][Full Text] [Related]
25. Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: An fMRI study.
Potvin S; Tikàsz A; Lungu O; Dumais A; Stip E; Mendrek A
Schizophr Res; 2015 Oct; 168(1-2):377-80. PubMed ID: 26255082
[TBL] [Abstract][Full Text] [Related]
26. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
[No Abstract] [Full Text] [Related]
27. Combination treatments for schizophrenia.
Miller AL
CNS Spectr; 2004 Sep; 9(9 Suppl 9):19-23. PubMed ID: 15361808
[TBL] [Abstract][Full Text] [Related]
28. Stimulants for impulsive violence in schizophrenia spectrum disordered women: a case series and brief review.
Skoretz P; Tang C
CNS Spectr; 2016 Dec; 21(6):445-449. PubMed ID: 27181114
[TBL] [Abstract][Full Text] [Related]
29. Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia.
Pinto A; La Pia S; Mennella R; Giorgio D; DeSimone L
Psychiatr Serv; 1999 Jul; 50(7):901-4. PubMed ID: 10402608
[No Abstract] [Full Text] [Related]
30. Can cognitive remediation improve subsequent response to low-intensity cognitive behaviour therapy for psychosis in people with schizophrenia?
Naeem F
Aust N Z J Psychiatry; 2017 Feb; 51(2):117-118. PubMed ID: 27920065
[No Abstract] [Full Text] [Related]
31. Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.
Kinoshita M; Numata S; Tajima A; Yamamori H; Yasuda Y; Fujimoto M; Watanabe S; Umehara H; Shimodera S; Nakazawa T; Kikuchi M; Nakaya A; Hashimoto H; Imoto I; Hashimoto R; Ohmori T
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335437
[TBL] [Abstract][Full Text] [Related]
32. A rational approach to employing high plasma levels of antipsychotics for violence associated with schizophrenia: case vignettes.
Meyer JM
CNS Spectr; 2014 Oct; 19(5):432-8. PubMed ID: 24865765
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
Woodward ND; Purdon SE; Meltzer HY; Zald DH
Int J Neuropsychopharmacol; 2005 Sep; 8(3):457-72. PubMed ID: 15784157
[TBL] [Abstract][Full Text] [Related]
34. Successful use of maintenance electroconvulsive therapy in the treatment of clozapine-associated obsessive-compulsive symptoms in schizophrenia: a case report.
Rao NP; Antony A; Raveendranathan D; Venkatasubramanian G; Behere RV; Varambally SS; Gangadhar BN
J ECT; 2011 Mar; 27(1):e37-8. PubMed ID: 20938347
[TBL] [Abstract][Full Text] [Related]
35. The effects of clozapine on cognitive functioning in schizophrenia.
McGurk SR
J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
[TBL] [Abstract][Full Text] [Related]
36. Psychosis and violence: stories, fears, and reality.
Taylor PJ
Can J Psychiatry; 2008 Oct; 53(10):647-59. PubMed ID: 18940033
[TBL] [Abstract][Full Text] [Related]
37. Functioning and cognitive characteristics of clozapine users referred to psychosocial rehabilitation centers: A REHABase cohort study.
Verdoux H; Quiles C; Cervello S; Dubreucq J; Bon L; Massoubre C; Pommier R; Legros-Lafarge E; Jaafari N; Guillard-Bouhet N; Chéreau-Boudet I; Couhet G; Plasse J; Franck N
Psychiatry Res; 2019 Nov; 281():112543. PubMed ID: 31493715
[TBL] [Abstract][Full Text] [Related]
38. Psychopharmacology of Persistent Violence and Aggression.
Meyer JM; Cummings MA; Proctor G; Stahl SM
Psychiatr Clin North Am; 2016 Dec; 39(4):541-556. PubMed ID: 27836150
[TBL] [Abstract][Full Text] [Related]
39. New Clinically Relevant Findings about Violence by People with Schizophrenia.
Hodgins S; Klein S
Can J Psychiatry; 2017 Feb; 62(2):86-93. PubMed ID: 27605579
[TBL] [Abstract][Full Text] [Related]
40. Predictors of cognitive and functional improvement and normalization after cognitive remediation in patients with schizophrenia.
Vita A; Deste G; De Peri L; Barlati S; Poli R; Cesana BM; Sacchetti E
Schizophr Res; 2013 Oct; 150(1):51-7. PubMed ID: 23998953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
